Opening discussion on the advent of differentiated thyroid cancer (DTC) and management, moderator Lori J. Wirth, MD, provides and overview of prevalence, subtypes, and prognosis.
Marcia Brose, MD, PhD, University of Pennsylvania
Advertisement
Articles by Marcia Brose, MD, PhD, University of Pennsylvania
Advertisement
Latest Updated Articles
Overview on Differentiated Thyroid Cancer (DTC)April 17th 2023
Advertisement
Advertisement
Trending on OncLive
1
Five Under 5: Top Oncology Videos for the Week of 8/31/26
2
FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer
3
CARiBOU Regimen Drives Complete Metabolic Responses in First-Line Mantle Cell Lymphoma
4
B7-H4–Targeted ADCs Signal a New Frontier for Platinum-Resistant Ovarian and Endometrial Cancer
5